contact us
JADO Technologies GmbH
  • Overview
  • Senior Management
  • Advisory Board
  • Scientific Advisors
  • Investors
  • Overview
  • Miltefosine
  • Role of Cell Membranes in Key Biological Processes
  • Membrane and Raft Intervention
  • home
  • about
  • pipeline
  • technology
  • applications
  • partner network
  • newsroom
 
  • Overview
  • Miltefosine

Pipeline

Overview

JADO is focusing its initial drug development efforts in allergy and inflammatory diseases (e.g. atopic dermatitis, mastocytosis, urticaria).

These diseases have high unmet medical need, with current therapeutics unable to provide long-term benefit without associated side-effects.

The pharmaceutical industry is seeking drugs with new modes-of-action to address this growing need. We believe JADO's membrane domain targeting therapeutics have the ideal profile.
 

Copyright © 2005-2009 JADO Technologies GmbH. All Rights Reserved.  Terms of Use and Privacy